Portal vein thrombosis is a relatively rare but well-known complication of cirrhosis that has a prevalence of between 1% and 5.7%. On the contrary, in case of hepatocellular carcinoma (HCC), it is a much more frequent complication. In this paper, we presented three cases that had liver cirrhosis, mass and portal vein thrombosis in liver. We were not able to diagnose the cases through imaging methods, laboratory results or histopathologically, however, they were diagnosed with endoscopic ultrasonography-fine needle aspiration EUS-FNA from portal vein thrombus.
Introduction
Up to 70% of patients with HCC experience tumor invasion into the portal vein (PV) by direct venous extension or metastasis [1] . When patients display a liver mass expressive of HCC and PV thrombus that intensifies on arterial phase of computer tomography (CT) or magnetic resonance imaging (MRI), the diagnosis of a tumor thrombus is relatively easy. On the other hand, when there is no discrete or infiltrating liver mass or when there is nondiagnostic increase of AFP level or equivocal intensification of tumor thrombus, tumor thrombosis diagnosis is difficult. A definite diagnosis or exclusion of tumor thrombus becomes critically important in case of liver transplantation or a curative resection; thus, tissue diagnosis is always confirmatory [2, 3] . The feasibility and safety of fine needle aspiration (FNA) of PV thrombus under transcutaneous ultrasonography guidance has been described by a number of case series. Yet, due to technical difficulties, this is not widely used [1] .
However, although there are only few interventions with endoscopic ultrasonography (EUS)-FNA, it has been reported that it should be used as the first choice since it is easy to apply, safe and since it has a high chance of success [2, 4] . In this paper, we presented three cases that had liver cirrhosis, mass and portal vein thrombosis in liver. We were not able to diagnose the cases through imaging methods, laboratory results or histopathologically, however, they were diagnosed with EUS-FNA from PV thrombus.
Patient and observation case 1
48 year-old male patient was hospitalized with a complaint of abdominal pain and nausea that had been going on for about eight months. The patient had no peculiarity in his anamnesis and family history. The patient had been smoking for 10 package/years. His Attempts of curative treatment options can be made only when extensive vascular invasion or extrahepatic spread are absent. Since the present laboratory tests lack adequate sensitivity or specificity, HCC is usually diagnosed by radiologic imaging [2] . HCC can also be diagnosed through noninvasive radiologic imaging modalities, however, these techniques also do not have adequate accuracy when diagnoses are made without tissue sampling [5] . When a mass is found on imaging, increase alphafetoprotein (AFP) level (>200 ng/mL), or a rising AFP level has a very high positive predictive value in the diagnosis of HCC [2] . Yet, at the time of diagnosis 30% of patients have normal AFP levels and they usually remain low, even with advanced HCC [6] . AFP specificity is close to 100% with such values; however, this causes sensitivity to fall by 45% [7] . The positive predictive value (PPV) of AFP is low, with percentages ranging from 9% to 32% [8] . Although all our cases had tumoral portal vein thrombosis, AFP levels were normal.
Conventional In all our three cases, imaging methods were not typical of HCC and PVTT.
In a great number of previous studies, transabdominal (TA) USguided FNA has been shown to be effective and safe. In Dusenbery et al's study [10] , in biopsies, 39 patients were reported to be positive (81.3%), 3 patients were reported to be dubiously positive (6.2%) and only 6 patients were reported to be negative (12.5%). and reliable visualization of the PV, its content, and surrounding tissue and organs. In addition, the FNA needle has to go only a short distance which causes the procedure to be quick and precise [2] . Avoiding the common bile duct and vasculature, particularly collateral vessels, the FNA needle can be positioned directly into the PVT. As a result, complications can be minimized, at least in theory.
A lower potential for needle tract seeding is another advantage of EUS-guided FNA over percutaneous US-or CT-guided FNA [4] .
Conclusion
As a conclusion, this study shows once more that EUS-FNA is an easy, safe and effective procedure. We recommend the use of EUS- 
